Explore Your Options
Schedule a consultation with a CSRHub team member to explore your use case and discuss a tailored solution.
You've reached the limit for free Overall Ranking scores. For more information, request a demo.
See CSRHub in Action
You have a total of 10 free searches available.
Corporate Social Responsibility (CSR) & Environment, Social, Governance (ESG) Metrics
BioMarin Pharmaceutical Inc. ESG Ranking
|
|
ESG Ranking (%)
Compared With 37,899 Companies |
Low
0-29
30-39
40-49
50-59
60-79
80-100
High
30
Sources
for this company
?
for this company
1 Special Issue
Affects This Company
30
Sources
for this company
?
for this company
1 Special Issue
Affects This Company
BioMarin is a multinational biopharmaceutical company that specializes in providing first-to-market therapeutics to patients with rare genetic diseases. The company's product portfolio comprises three approved products and multiple clinical and preclinical product candidates. Approved products include Naglazyme for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan Tablets, a product for the treatment of phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. The company was established in 1997 and employs a staff of 675 worldwide.
| Ticker: | BMRN |
| ISIN: | US09061G1013 |
| Address: |
105 Digital Drive |
| Novato, CA, 94949, USA | |
| Website: | BioMarin Pharmaceutical Inc. |
| Phone #: | 4155066700 |
| ESG Web Area: | Subscribers Only ? |
| Industry: | Biotechnology |
Who Uses CSRHub and How
Companies face a complex ESG landscape with many raters and little coherence.
CSRHub’s data and tools solve these problems.
Corporate Managers
-
Benchmark against your peers
-
Improve stakeholder communication
-
Pinpoint ESG reporting gaps
-
Review your supply chain
-
Uncover ESG business opportunities
Consultants
-
Expand your ESG expertise
-
Find and focus on the best reporting strategy
-
Propose innovations and drive change
-
Communicate with all levels of management
-
Build client ESG knowledge
Supply Chain Professionals
-
Rapidly review your supply chain
-
Proactively identify and address risk
-
Assess and improve supplier performance
-
Access easy-to-use tools to fit into your management system
Investment Professionals
-
Screen your investment universe
-
Back test to find material ESG indicators
-
Share your ESG strategy with clients
-
Engage with companies
-
Improve asset owner reporting
See more information for Nonprofit and Government, Academic Researchers and API Developers.
CSRHub includes data on GRI, Sustainability, Leadership Ethics, esg investing, ESG, and Task Force for Climate Related Financial Disclosure.
See Your Roadmap for
Company Ratings Improvement
with the new CSRHub ESG Ratings Lever below
We Harmonize Global ESG Data
Your title or message
Sources
{{sources_count}}
for
Companies
{{companies_count}}
in
Countries
{{countries_count}}
Your title or message
.jpg?width=219&name=B%20Corporation%20-%20GIIRS%20(1).jpg)
.svg)
Summary of the data sources currently reporting on BioMarin Pharmaceutical Inc. and some examples
ESG
Analysts
{{ esgAnalystsDatasources.length }}
Reporting
Systems
{{reportingSystemsDatasources.length}}
Expert
Publications
{{ expertPublicationDatasources.length }}
Nonprofit
Sources
{{nonprofitDatasources.length }}
How to Get Our Data
Website Browsing
Excel Dashboards
RESTful API
Distributors and Integrators
Name Variants for BioMarin Pharmaceutical Inc.
Scroll